Get the Stockscreener App
25.53
0.41%
0.1046
Cencora Inc stock is traded at $25.53, with a volume of 1,361.
It is up +0.41% in the last 24 hours and down -1.03% over the past month.
See More
Previous Close:
$25.43
Open:
$25.56
24h Volume:
1,361
Relative Volume:
0.41
Market Cap:
$25.02M
Revenue:
Net Income/Loss:
P/E Ratio:
-
EPS:
-
Net Cash Flow:
1W Performance:
+1.89%
1M Performance:
-1.03%
6M Performance:
-1.86%
1Y Performance:
-2.98%
1-Day Range:
$25.53
$25.62
1-Week Range:
$25.11
$25.49
52-Week Range:
$24.98
$27.70
Cencora Inc Stock (CCOR) Company Profile
Compare CCOR vs VOO, IVV, SPY, VTI, QQQ
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CCOR
Cencora Inc
|
25.53 | 25.02M | 0 | 0 | 0 | 0.00 |
VOO
Vanguard S P 500 Etf
|
714.79 | 1.05T | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
781.08 | 896.29B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
777.62 | 821.27B | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
381.41 | 702.48B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
745.69 | 498.72B | 0 | 0 | 0 | 0.00 |
Cencora Inc Stock (CCOR) Latest News
5 Best Emerging Markets ETFs for 2026 and How to Invest - The Motley Fool
What are private markets? - BlackRock
$1000 Invested In Cencora 10 Years Ago Would Be Worth This Much Today - Benzinga
Cencora (COR) ex-officer lines up new stock sale - Stock Titan
Cencora (COR) Stock Forecast and Price Target 2026 $COR - MarketBeat
Cencora stock heads into the open after a 0.1% dip - ad-hoc-news.de
Cencora Inc. stock dips after RBC reiterates cautious price target - ad-hoc-news.de
Is Cencora Stock Underperforming the Dow? - inkl
Cencora stock price target maintained at $330 by RBC Capital By Investing.com - Investing.com Australia
Cencora stock heads into the open after a modest decline - ad-hoc-news.de
Cencora stock holds firm after RBC keeps $330 target - ad-hoc-news.de
Cencora Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Cencora stock price target maintained at $330 by RBC Capital - Investing.com Canada
Cencora stock price target maintained at $330 by RBC Capital - Investing.com India
Cencora stock price target maintained at $330 by RBC Capital - Investing.com
Cencora stock price target maintained at $330 by RBC Capital - Investing.com South Africa
Cencora, Inc. (COR) Stock Analysis: Robust Growth in Medical Distribution with an 11.59% Upside Potential - directorstalkinterviews.com
Cencora Inc. stock gains on solid fiscal 2026 momentum - ad-hoc-news.de
Why Cencora (COR) Is Getting Attention Today - simplywall.st
Cencora stock gains on solid fiscal 2026 earnings momentum - AD HOC NEWS
Cencora’s New Cell and Gene Services Might Change The Case For Investing In Cencora (COR) - simplywall.st
Cencora Inc. stock underperforms Friday when compared to competitors - MarketWatch
Here's Why You Should Retain Cencora Stock in Your Portfolio for Now - finance.yahoo.com
Former Cencora (NYSE: COR) leader lines up another stock sale - Stock Titan
Cencora Inc. stock gains on new cell and gene therapy service and strong guidance - ad-hoc-news.de
Cencora (COR) Up 3.8% Since Last Earnings Report: Can It Continue? - finance.yahoo.com
Cencora Launches Cell and Gene Therapy Enablement for Health Systems - finance.yahoo.com
Is Cencora (COR) Still Undervalued On Higher 2026 Guidance And Strong Q3 Earnings? - Yahoo Finance
Cencora (COR) Unveils Cell And Gene Therapy Enablement Service - simplywall.st
What Cencora (COR)'s Cell and Gene Push and Higher 2026 Outlook Means For Shareholders - finance.yahoo.com
Cencora Raises 2026 EPS Outlook as Specialty Businesses Strengthen - Eastern Progress
Cencora Launches Cell and Gene Therapy Enablement to Help Health Systems Build and Scale Programs - BioBuzz
Artisan Sold Cencora (COR) as Earnings Momentum Slowed - Yahoo Finance
Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch
Cencora (NYSE: COR) executive sells 985 shares in preset plan - Stock Titan
Cencora stock gains after guidance increase and resilient Q2 performance - AD HOC NEWS
Cencora Launches Cell and Gene Therapy Enablement Service Through Accelerate Pharmacy Solutions - marketscreener.com
Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch
Cencora Inc. stock reflects insider sale plans and steady growth outlook - ad-hoc-news.de
Former Cencora (NYSE: COR) executive lines up stock sale after restricted shares vest - stocktitan.net
Cencora, Inc. (COR) Stock Analysis: A Healthcare Powerhouse with 14.68% Potential Upside - directorstalkinterviews.com
Cencora Executive VP & Chief Legal Officer Elizabeth Campbell Sells 37% Of Holding - simplywall.st
Extending capacity through alternative solutions: The rise of third-party capital - munichre.com
Cencora (COR) Earnings History & Trends - 24/7 Wall St.
Elizabeth S Campbell Takes Money Off The Table, Sells $3.66M In Cencora Stock - benzinga.com
Is Cencora (COR) Still Undervalued Following Its Board Resignation News? - sahmcapital.com
Cencora, Inc. (COR) Stock Analysis: A Healthcare Giant With A 16% Upside Potential - directorstalkinterviews.com
Paralel Advisors LLC Purchases New Position in Cencora, Inc. $COR - MarketBeat
Silvant Capital Management LLC Invests $11.93 Million in Cencora, Inc. $COR - MarketBeat
$100 Invested In Cencora 10 Years Ago Would Be Worth This Much Today - Sahm
Cencora Inc Stock (CCOR) Financials Data
There is no financial data for Cencora Inc (CCOR). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.48%
0.62%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):